Literature DB >> 22305769

Rodent models for HIV-associated neurocognitive disorders.

Santhi Gorantla1, Larisa Poluektova, Howard E Gendelman.   

Abstract

Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) reflect the spectrum of neural impairments seen during chronic viral infection. Current research efforts focus on improving antiretroviral and adjunctive therapies, defining disease onset and progression, facilitating drug delivery, and halting neurodegeneration and viral resistance. Because HIV is species-specific, generating disease in small-animal models has proved challenging. After two decades of research, rodent HAND models now include those containing a human immune system. Antiviral responses, neuroinflammation and immunocyte blood-brain barrier (BBB) trafficking follow HIV infection in these rodent models. We review these and other rodent models of HAND and discuss their unmet potential in reflecting human pathobiology and in facilitating disease monitoring and therapeutic discoveries. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22305769      PMCID: PMC3294256          DOI: 10.1016/j.tins.2011.12.006

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  119 in total

1.  HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta.

Authors:  Hui Peng; Nathan Erdmann; Nicholas Whitney; Huangyu Dou; Santhi Gorantla; Howard E Gendelman; Anuja Ghorpade; Jialin Zheng
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

2.  HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Authors:  Christine Goffinet; Ina Allespach; Oliver T Keppler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

3.  CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.

Authors:  Jinglin Sun; Timothy Soos; Vineet N Kewalramani; Kristin Osiecki; Jian Hua Zheng; Laurie Falkin; Laura Santambrogio; Dan R Littman; Harris Goldstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis.

Authors:  Raghava Potula; James Haorah; Bryan Knipe; Jessica Leibhart; Jesse Chrastil; David Heilman; Huanyu Dou; Rindha Reddy; Anuja Ghorpade; Yuri Persidsky
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

Authors:  Santhi Gorantla; Hannah Sneller; Lisa Walters; John G Sharp; Samuel J Pirruccello; John T West; Charles Wood; Stephen Dewhurst; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.

Authors:  Gareth J Jones; Nicola L Barsby; Eric A Cohen; Janet Holden; Kim Harris; Peter Dickie; Jack Jhamandas; Christopher Power
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

7.  Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.

Authors:  Satoru Watanabe; Kazuo Terashima; Shinrai Ohta; Shigeo Horibata; Misako Yajima; Yoko Shiozawa; M Zahidunnabi Dewan; Zhong Yu; Mamoru Ito; Tomohiro Morio; Norio Shimizu; Mitsuo Honda; Naoki Yamamoto
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

8.  Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.

Authors:  Huanyu Dou; Justin Morehead; Jennifer Bradley; Santhi Gorantla; Brent Ellison; Jeff Kingsley; Lynette M Smith; Wei Chao; Galina Bentsman; David J Volsky; Howard E Gendelman
Journal:  Glia       Date:  2006-08-01       Impact factor: 7.452

Review 9.  Molecular and cellular mechanisms of neuronal cell death in HIV dementia.

Authors:  W Li; D Galey; M P Mattson; A Nath
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

10.  An immune control model for viral replication in the CNS during presymptomatic HIV infection.

Authors:  M McCrossan; M Marsden; F W Carnie; S Minnis; B Hansoti; I C Anthony; R P Brettle; J E Bell; P Simmonds
Journal:  Brain       Date:  2005-11-29       Impact factor: 13.501

View more
  46 in total

Review 1.  Humanized mouse models for HIV-1 infection of the CNS.

Authors:  Jenna B Honeycutt; Patricia A Sheridan; Glenn K Matsushima; J Victor Garcia
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

2.  Brain region mapping using global metabolomics.

Authors:  Julijana Ivanisevic; Adrian A Epstein; Michael E Kurczy; Paul H Benton; Winnie Uritboonthai; Howard S Fox; Michael D Boska; Howard E Gendelman; Gary Siuzdak
Journal:  Chem Biol       Date:  2014-11-20

3.  Insights into end-organ injury in HIV infection: dynamics of monocyte trafficking to the brain in SIV encephalitis.

Authors:  Yuri Persidsky
Journal:  Am J Pathol       Date:  2015-05-08       Impact factor: 4.307

4.  Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice.

Authors:  Aditya N Bade; Santhi Gorantla; Prasanta K Dash; Edward Makarov; Balasrinivasa R Sajja; Larisa Y Poluektova; Jiangtao Luo; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  Mol Neurobiol       Date:  2015-06-11       Impact factor: 5.590

5.  Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis.

Authors:  Raghubendra Singh Dagur; Weimin Wang; Edward Makarov; Yimin Sun; Larisa Y Poluektova
Journal:  J Vis Exp       Date:  2019-09-11       Impact factor: 1.355

Review 6.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

Review 7.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

Review 8.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

9.  Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

Authors:  Prasanta K Dash; Howard E Gendelman; Upal Roy; Shantanu Balkundi; Yazen Alnouti; Rodney L Mosley; Harris A Gelbard; Joellyn McMillan; Santhi Gorantla; Larisa Y Poluektova
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

10.  HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.

Authors:  Robert F Roscoe; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2014-07-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.